Khaled Moussally Joins FDA and GSK Experts for a Featured Session on AI-Enabled Compliance

LIBERTYVILLE, IL, UNITED STATES, October 12, 2026 /EINPresswire.com/ — Compliance Group Inc. Is excited to participate in the 2026 ISPE Annual Meeting & Expo, taking place October 18–21, 2026, in Washington, D.C., and virtually. The event brings together pharmaceutical and biopharmaceutical professionals to exchange insights, explore industry advancements, and discuss emerging technologies and regulatory developments.

Compliance Group will highlight its expertise in AI-enabled quality, compliance, and validation, demonstrating how AI-powered solutions can help life sciences organizations streamline quality workflows, improve efficiency, and support risk-based decision-making while maintaining regulatory rigor.

Featured Session:

As part of the conference program, Khaled Moussally, EVP Managing Partner, Compliance Group, will speak alongside Daniel Walter (Policy Analyst, FDA) and Louie Rayal (VP, Governance Risk & Compliance, GSK) in a session titled: “Autonomous Quality Systems – AI-Enabled Compliance.”
Date & Time: October 20, 2026 | 11:30 AM–12:00 PM
Session Abstract:
AI is emerging as a practical approach to accelerating validation while maintaining regulatory rigor. This session will explore its application across the validation lifecycle within a Computer Software Assurance (CSA) framework, from risk assessment and FMEA to test script generation, execution traceability, and summary reporting, aligned with FDA CSA guidance, ICH Q9(R1), and GAMP 5 Second Edition.
Attendees will learn how AI can support risk-based testing, identify critical functionality, and generate audit-ready rationale while keeping human judgment central to patient-safety decisions. The discussion will also address key considerations, including data integrity, human oversight, and auditability of AI-assisted decisions.

Explore AI-Powered Solutions and Meet Our Team at Booth 907

Visit Compliance Group Inc. at Booth 907 to meet our team and experience live demos of iQuality and our AI agents: Audit Trail Review [ATR], Annual Product Quality Review [APQR], and Digital Validation Documentation [VERA], powered by CLAiRE, the Agentic AI Platform. Discover how our AI-driven capabilities can streamline quality workflows, strengthen compliance, and support efficient, risk-based approaches to quality and validation in regulated life sciences environments.
Connect with Khaled Moussally, Jonathan Meuzelaar, Venkata Phani Kiran Nandula, Sarada Ramamoorthy, Hillary Driscoll, Elizabeth Prager, Emily Carolan, and Theresa Noonan to exchange insights and explore how AI can advance quality, compliance, and validation across the life sciences industry.

About Compliance Group

Compliance Group (CG) is a global provider of quality, validation, regulatory compliance, digital transformation, specialized resourcing, managed services, and AI-enabled solutions for life sciences organizations. Guided by the mission to “Accelerate Innovation in Life Sciences,” CG helps organizations modernize compliance, streamline validation, and adopt emerging technologies with confidence. By combining deep industry expertise with innovative technology, CG enables regulated companies to strengthen quality, improve operational performance, and navigate an increasingly complex regulatory landscape.
For more information about CG’s AI capabilities, visit www.complianceg.com

Bhawna Gupta
Compliance Group Inc
+1 609-431-5508
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Media gallery

About The Author
Written By: EIN Presswire